Canada markets open in 48 minutes

LAVA Therapeutics N.V. (LVTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.2600-0.1400 (-5.83%)
At close: 04:00PM EDT
2.3800 +0.12 (+5.31%)
Pre-Market: 08:34AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
12,537
6,769
19,391
5,350
3,747
Cost of Revenue
2,552
3,482
0
0
-
Gross Profit
9,985
3,287
19,391
5,350
-
Operating Expenses
Research Development
29,880
33,814
40,105
36,945
15,701
Selling General and Administrative
11,771
12,726
14,124
12,018
2,719
Total Operating Expenses
41,651
46,540
54,229
48,963
18,420
Operating Income or Loss
-31,666
-43,253
-34,838
-43,613
-14,673
Interest Expense
-
232
82
625
342
Total Other Income/Expenses Net
193
-1,412
2,923
2,040
-869
Income Before Tax
-28,310
-41,695
-31,658
-42,198
-15,884
Income Tax Expense
277
279
249
157
43
Income from Continuing Operations
-28,587
-41,974
-31,907
-42,355
-15,927
Net Income
-28,587
-41,974
-31,907
-42,355
-15,927
Net Income available to common shareholders
-28,587
-41,974
-31,907
-42,355
-15,927
Basic EPS
-1.92
-1.57
-1.23
-2.14
-0.63
Diluted EPS
-1.92
-1.57
-1.23
-2.14
-0.63
Basic Average Shares
26,290
26,733
25,924
19,758
25,352
Diluted Average Shares
26,290
26,733
25,924
19,758
25,352